Company · CIK 0001739426 · SIC 2834 — Pharmaceutical Preparations
Osmotica Pharmaceuticals plc · OSMT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2019 AForm 4 → | Feb 27, 5:32 pm EST | Brian A MarkisonChief Executive Officer, Director | 387,991 | — | — | 1,876,233 | — | plan? |
| Jan 24, 2019 AForm 4 → | Jan 28, 5:50 pm EST | Fred G WeissDirector | 34,403 | — | — | 34,403 | — | plan? |
| Jan 24, 2019 AForm 4 → | Jan 28, 5:50 pm EST | Tina Marie deVriesEVP, Research & Development | 104,849 | — | — | 104,849 | — | plan? |
| Jan 24, 2019 AForm 4 → | Jan 28, 5:49 pm EST | James SchaubEVP and COO | 104,849 | — | — | 264,352 | — | plan? |
| Jan 24, 2019 AForm 4 → | Jan 28, 5:49 pm EST | Andrew J. EinhornChief Financial Officer | 104,849 | — | — | 104,849 | — | plan? |
| Jan 24, 2019 AForm 4 → | Jan 28, 5:49 pm EST | Christopher KleinGeneral Counsel and Secretary | 104,849 | — | — | 165,032 | — | plan? |
| Jan 24, 2019 AForm 4 → | Jan 28, 5:48 pm EST | Gregory L CowanDirector | 34,403 | — | — | 34,403 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.